Found: 19
Select item for more details and to access through your institution.
In vivo and in vitro characterization of GL0034, a novel long‐acting glucagon‐like peptide‐1 receptor agonist.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2090, doi. 10.1111/dom.14794
- By:
- Publication type:
- Article
Analytical characterization of recombinant hCG and comparative studies with reference product.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 23, doi. 10.2147/BTT.S141203
- By:
- Publication type:
- Article
87-LB: Binding Kinetics, Bias, Receptor Internalization, and Effects on Insulin Secretion for a Novel GLP1R-GIPR Dual Agonist, HISHS-2001.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-87-LB
- By:
- Publication type:
- Article
638-P: A Novel, Long-Acting Dual Agonist for GIPR/GLP-1R, HISHS-2001, Demonstrates Effects on HbA1c and Weight Loss in the db/db Mouse Model of Type 2 Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-638-P
- By:
- Publication type:
- Article
946-P: The GLP-1 Receptor Agonist GL0034 Activates Central Regions Controlling Glucose Homeostasis and Feeding Behavior.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-946-P
- By:
- Publication type:
- Article
350-OR: A Novel Long-Acting GLP-1 Agonist (GL0034) Demonstrates Remarkable Efficacy on HbA1c, Weight Loss, and Triglycerides in a Model of Type 2 Diabetes, the db/db Mouse.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-350-OR
- By:
- Publication type:
- Article
2100-P: Binding Kinetics, GLP-1 Receptor Internalization, and Effects on Insulin Secretion for GL0034 and Related GLP-1R Agonists.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2100-P
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 6, p. 428, doi. 10.1002/cpdd.136
- By:
- Publication type:
- Article
Simultaneous Quantitative Determination of Bupropion and its Metabolites by High Performance Liquid Chromatography Tandem Mass Spectrometry Detection: Application to Bioequivalence Study.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2018, v. 52, p. 37, doi. 10.5530/ijper.52.4s.74
- By:
- Publication type:
- Article
Characterization of Anti-Inflammatory Properties and Evidence for No Sedation Liability for the Novel Antihistamine SUN-1334H.
- Published in:
- International Archives of Allergy & Immunology, 2009, v. 151, n. 1, p. 56, doi. 10.1159/000232571
- By:
- Publication type:
- Article
Preclinical Efficacy and Safety Pharmacology of SUN-1334H, a Potent Orally Active Antihistamine Agent.
- Published in:
- Drugs in R&D, 2008, v. 9, n. 2, p. 93, doi. 10.2165/00126839-200809020-00004
- By:
- Publication type:
- Article
Induction of Glucose Intolerance by Acute Administration of Rimonabant.
- Published in:
- Pharmacology, 2012, v. 89, n. 5/6, p. 339, doi. 10.1159/000337731
- By:
- Publication type:
- Article
Molecular Container and Metal Ion Sensor Chiral Cavitands.
- Published in:
- ChemistrySelect, 2020, v. 5, n. 34, p. 10588, doi. 10.1002/slct.202002273
- By:
- Publication type:
- Article
Mitochondria targeted esculetin administration improves insulin resistance and hyperglycemia-induced atherosclerosis in db/db mice.
- Published in:
- Journal of Molecular Medicine, 2024, v. 102, n. 7, p. 927, doi. 10.1007/s00109-024-02449-1
- By:
- Publication type:
- Article
Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil<sup>®</sup> or Caelyx<sup>®</sup> in advanced ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx<sup>®</sup> (doxorubicin HCl liposome injection) in syngeneic fibrosarcoma-bearing BALB/c mice and Sprague-Dawley rats.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Correction to: Therapeutic efficacies of mitochondria‑targeted esculetin and metformin in the improvement of age‑associated atherosclerosis via regulating AMPK activation.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation.
- Published in:
- GeroScience, 2024, v. 46, n. 2, p. 2391, doi. 10.1007/s11357-023-01015-w
- By:
- Publication type:
- Article
Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
- Published in:
- 2017
- By:
- Publication type:
- journal article